The early use of ASPIRIN in COVID-19 patients

in #covid19last year


The early use of aspirin in covid-19 patients, which also has the effects of inhibiting virus replication, anti-platelet aggregation, anti-inflammatory and anti-lung injury, is expected to reduce the incidence of severe and critical patients, shorten the length of hospital duration and reduce the incidence of cardiovascular complications.

Protective Effect of Aspirin on COVID-19 Patients (PEAC)